Europe Markets for Bone Graft Substitutes 2015 – MedSuite

Europe Markets for Bone Graft Substitutes 2015 – MedSuite

0

Bones are biologically active tissues that allow for movement, provide protection for the body’s other organs and serve as a production center for red and white blood cells. When bones are diseased or damaged, bone grafts and bone graft substitutes are used for bridging the resulting void or for providing the support that has been lost. The transplanted (or implanted) material provides a scaffold on which the body can generate new bone tissue, thereby repairing the skeletal system. The most common usage of such materials is for dental implants to replace missing teeth. Within the orthopedic field, however, spinal fusion surgeries are the largest driver of bone graft and bone graft substitute usage. Direct competition for bone graft substitutes comes from bone morphogenetic proteins which, although more expensive, are more effective at stimulating bone growth. Another source of competition is the rise of the motion preservation market for spinal surgery.

  • Year: 2015
  • Scope: 2011-2021
  • Region: Europe
  • Published Date: 06/01/2015
  • Pages: 236
  • Type: MedCore

In this report, bone graft substitute products were segmented into allografts, demineralized bone matrices
(DBMs) and synthetics. A common trend seen in the BGS market has been the increase in demand for
synthetic materials. Due to the lower ASP and the ease at which these products can be used, demand for
synthetics is steadily increasing. In addition to the lower price and easy accessibility, the entire market is
being driven by synthetics.



The "Europe Market for Orthopedic Biomaterials 2015 - MedSuite" includes analysis on the following companies currently active in this market:
Fidia
Medtronic
Sanofi
Smith and Nephew
Meda Pharma
TRB Chemedica
Depuy Synthes
Laboratoire Genevrier
Recordati
Stryker
RTI Biologics
Tedec Meiji
Sobi
Biomet
Croma-Pharma
Wright Medical
Zimmer
Fin-Ceramica
Baxter
Bonalive
Seikagaku
Others include: Alphatec Spine, Anika Therpeutics, Biocomposites Ltd, Bioiberica, Biomatlante, Curasan, Documedica, Exactech, Ferring, Geistlich LCA

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link